The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-Hydroxy-2-oxo-1-phenylpyrrolidine-3-carboxylic Acid 3-Chloro-5-fluorobenzylamide ID: ALA4552396
PubChem CID: 89893711
Max Phase: Preclinical
Molecular Formula: C18H16ClFN2O3
Molecular Weight: 362.79
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1cc(F)cc(Cl)c1)[C@@]1(O)CCN(c2ccccc2)C1=O
Standard InChI: InChI=1S/C18H16ClFN2O3/c19-13-8-12(9-14(20)10-13)11-21-16(23)18(25)6-7-22(17(18)24)15-4-2-1-3-5-15/h1-5,8-10,25H,6-7,11H2,(H,21,23)/t18-/m0/s1
Standard InChI Key: GYXUHDDOWYYRFT-SFHVURJKSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
36.8092 -4.4699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6090 -4.6865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3967 -3.8856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3243 -7.1943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3232 -8.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0379 -8.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7541 -8.0210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7513 -7.1907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0361 -6.7816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0277 -5.9559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6936 -5.4691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4363 -4.6854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3590 -5.4731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5753 -5.7303 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.9816 -3.3039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6006 -3.6699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.7776 -3.5195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3625 -2.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1581 -3.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7426 -2.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5315 -1.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7306 -1.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1495 -2.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5164 -0.7660 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
41.5387 -2.7910 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 1 0
12 2 1 0
2 13 1 0
13 10 1 0
9 10 1 0
13 14 2 0
3 15 1 0
3 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
22 24 1 0
20 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.79Molecular Weight (Monoisotopic): 362.0833AlogP: 2.26#Rotatable Bonds: 4Polar Surface Area: 69.64Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.76CX Basic pKa: ┄CX LogP: 2.10CX LogD: 2.10Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.82Np Likeness Score: -1.18
References 1. Heinrich T, Seenisamy J, Blume B, Bomke J, Calderini M, Eckert U, Friese-Hamim M, Kohl R, Lehmann M, Leuthner B, Musil D, Rohdich F, Zenke FT.. (2019) Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors., 62 (10): [PMID:30939017 ] [10.1021/acs.jmedchem.9b00041 ]